Thursday, February 29, 2024
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina


clinical trials

Havana, Oct 9 (Prensa Latina) Cuban scientists are developing a Phase III clinical trial of the drug Jusvinza, with immunomodulatory and anti-inflammatory effects, in patients with rheumatoid arthritis, Granma newspaper reported.
Washington, Mar 17 (Prensa Latina) Syndax Pharmaceuticals, Inc. on Friday announced it found data from the Phase 1 portion of the ongoing Phase 1/2 AUGMENT-101 trial of revumenib in patients with nucleophosmin mutant (mNPM1) and KMT2A-rearranged (KMT2Ar) relapsed/refractory (R/R) acute leukemia.